Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on April 8, 2025
EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer
GlobeNewswire
·
April 8, 2025
BRANFORD, Conn. and NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced …
Comanche Biopharma Announces European Medicines Agency (EMA) Has Granted Orphan Drug Designation for CBP-4888 in sFlt1-mediated Preterm Preeclampsia
GlobeNewswire
·
April 8, 2025
EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically debilitating Preeclampsia, a serious obstetric complication, is a leading cause of near-term morbidity and mortality for mothers and …
Koryx Copper Provides Update on Zambia Projects and Planned 2025 Exploration Work Program
GlobeNewswire
·
April 8, 2025
Highlights Koryx Copper owns 51% of two highly prospective exploration licenses in the Zambian copper belt, with an option to earn up to 80% over the next 30 months. Over the last few months significant work was completed in preparation for the …
Aya Gold & Silver Reports High-Grade Drill Results at Boumadine, Extends Tizi Zone to 2.2km and Identifies New Regional Targets
GlobeNewswire
·
April 8, 2025
MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2024 - 2025 program at Boumadine in the Kingdom of Morocco. …
Aya Or & Argent publie des résultats de forage à haute teneur à Boumadine, augmente l’étendue de la zone Tizi à 2,2 km et identifie de nouvelles cibles régionales
GlobeNewswire
·
April 8, 2025
MONTRÉAL, 08 avr. 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer de nouveaux résultats de forage d’exploration à haute teneur issus de son programme 2024-2025 à Boumadine dans le …
Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
GlobeNewswire
·
April 8, 2025
Vancouver, Canada, April 08, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Telix Announces Cardinal Health for Gozellix Commercial Distribution
GlobeNewswire
·
April 8, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as one of its …
N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany
GlobeNewswire
·
April 8, 2025
New German regulation, Section 8a of the Renewable Energy Sources Act – EEG, allows expanded use of grid infrastructure, enabling high-value battery storage addition to flagship renewable energy site Neve Yarak, Israel, April 08, 2025 (GLOBE NEWSWIRE) -- …
Titan Appoints Kevin Hart as Chief Financial Officer
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) (“Titan” or the "Company") is pleased to announce the appointment of Mr. Kevin Hart as Chief Financial Officer, effective immediately. Kevin …
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
GlobeNewswire
·
April 8, 2025
PITTSBURGH, April 08, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced the …